Park Ha Biological Technology Co., Ltd. BYAH
2.77
(0.10)
(3.48%)
as of 25 Sep
- Market cap
- $6.5M
- P/E
- —
Follow BYAH
| Oct '16 | Dec '16 | Oct '17 | Dec '17 | Oct '22 | Dec '22 | Oct '23 | Dec '23 | Oct '24 | Oct '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
EV/Operating CF |
(0.25) | (0.25) | (0.25) | (0.25) | (0.25) | (0.25) | (0.25) | — | (0.25) | (1.68) |
EV/FCF |
(0.28) | (0.28) | (0.28) | (0.28) | (0.28) | (0.28) | (0.28) | — | (0.28) | (1.90) |
Quick Ratio |
1.33 | 1.33 | 1.09 | 1.09 | 1.43 | 1.43 | 1.43 | 0.00 | 1.33 | 2.34 |
Current Ratio |
1.33 | 1.33 | 1.09 | 1.09 | 1.75 | 1.75 | 1.75 | 0.00 | 1.87 | 2.92 |
Net Debt/EBITDA |
(5.16) | (5.16) | 2.60 | 2.60 | (0.85) | (0.85) | (0.86) | 0.00 | (0.67) | 0.16 |
Debt/Assets |
39.75% | 39.75% | 20.43% | 20.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.16 | 1.16 | 0.67 | 0.67 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Asset Turnover |
0.18 | 0.20 | 0.18 | 0.25 | 0.00 | 1.09 | 1.09 | 0.00 | 1.04 | 0.56 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | (1.52) | 2.01 | 0.00 |
Capex/Depreciation |
— | — | — | — | — | — | (1.13) | (1.13) | (3.77) | (0.81) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (64.13%) | (94.39%) | (205.69%) | 7,233.33% | (54.88%) | (809.89%) | 187.81% | 0.00% | 38.01% | (885.83%) | |
| (5.93%) | (6.36%) | (8.70%) | (11.98%) | 0.09% | 37.62% | 37.62% | 25.51% | 20.94% | (539.29%) | |
ROIC |
(2.61%) | (2.61%) | (15.07%) | (15.07%) | 0.00% | 0.00% | 0.00% | 0.00% | 51.75% | (7,284.30%) |
Return on Tangible Assets |
(69.18%) | (69.18%) | (278.21%) | (278.21%) | 87.67% | 87.67% | 87.67% | 32.35% | 33.62% | (644.88%) |
Average Days of Receivables |
38.73 | 38.73 | 62.43 | 62.43 | 110.77 | 110.77 | 110.77 | 0.00 | 226.69 | 89.33 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.26% | — | 1.54% | 9.43% |
Selling, General and Administrative Expense of Revenue |
51.29% | 51.29% | 57.24% | 57.24% | 38.09% | 38.09% | 31.91% | 0.00% | 49.38% | 1,034.09% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | 953.35% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39.35 | — | 38.11 | 34.30 |
Operating CF per Share |
— | — | — | — | — | — | 2.02 | 0.00 | 15.37 | 1.17 |
Capex per Share |
— | — | — | — | — | — | (0.36) | 0.00 | (1.37) | (1.21) |
Free Cash Flow per Share |
— | — | — | — | — | — | 1.66 | 0.00 | 14.00 | (0.04) |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.54 | — | 8.76 | 51.46 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.20 | — | 24.10 | 54.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | — | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.20 | — | 24.10 | 54.28 |
Free Cash Flow |
— | — | — | — | — | — | 0.10 | (0.75) | 0.87 | 0.00 |
Working Capital |
256.00 | 256.00 | 56.00 | 56.00 | 0.93 | 0.93 | 0.93 | 1.48 | 1.32 | 3.62 |
Capital Expenditures |
— | — | — | — | — | — | (0.02) | (0.02) | (0.09) | (0.09) |
Net Current Asset Value |
(1,056.00) | (1,056.00) | (597.00) | (597.00) | 0.92 | 0.92 | 0.92 | 1.48 | 1.27 | 3.54 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 | 0.04 |
Net Profit Margin |
(32.48%) | (32.48%) | (47.59%) | (47.59%) | 34.65% | 34.65% | 34.65% | 0.00% | 20.09% | (965.02%) |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.52 | 0.00 | 0.22 | 0.69 |
Cash ROIC |
(1.09%) | (1.09%) | (1.46%) | (1.46%) | (1.89%) | (1.89%) | 4.30% | 0.00% | 41.71% | (0.93%) |
Accounts Receivable Turnover |
8.46 | 9.42 | 6.33 | 5.85 | 0.06 | 3.30 | 3.30 | 0.00 | 1.61 | 2.41 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 1.77 | 7.89 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.24 | 3.24 | — | 2.33 | 1.94 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 231.44 | — | 45.04 | 30.74 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 112.55 | 112.55 | 112.55 | — | 133.63 | 192.62 |
Average Receivables |
73.50 | 66.00 | 72.00 | 78.00 | 39.37 | 0.75 | 0.75 | 1.11 | 1.48 | 1.05 |
Average Payables |
— | — | — | — | — | — | — | — | 0.11 | 0.02 |
Average Inventory |
— | — | — | — | — | 0.10 | 0.10 | — | 0.08 | 0.07 |
Average Assets |
3,408.50 | 3,175.00 | 2,493.00 | 1,811.00 | 906.63 | 2.26 | 2.26 | 1.88 | 2.29 | 4.52 |
Average Common Equity |
315.00 | 214.00 | 105.50 | (3.00) | (1.55) | (0.11) | 0.45 | — | 1.26 | 2.75 |
Columns are period end dates